CVS HEALTH Corp News
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
see moreCVS HEALTH Corp Market News
6d
CVS Health: PBM Rules, Guidance, Growth Signals Q1
- This article synthesizes the week's key developments affecting CVS Health—new PBM transparency mandates, strategic product rollouts highlighted at a major healthcare conference, and recent earnings guidance—and explains how these items are influencing CVS stock performance within the S&P 500.
13d
CVS Stock Gains as Institutions Increase Stakes Q1
Institutional investors have boosted CVS positions, lifting shares amid a short rally, while recent CMS announcements pressured health-insurer peers. The juxtaposition of stronger institutional ownership and sector-specific headwinds places CVS in a nuanced position driven by Aetna exposure and Caremark operations.
20d
CVS Faces Tennessee Law, Antitrust and Option Pain.
Recent state legislation, a House antitrust probe and a surge in bearish options have combined to raise regulatory and sentiment risks for CVS Health. Investors should weigh potential store closures, competitive moves by rivals, and heightened volatility when assessing CVS in the S&P 500.
27d
CVS Stock Hits Rough Patch After MA Rate Cut
CVS delivered record 2025 revenue but falling EPS and a near-flat Medicare Advantage rate proposal from CMS pressured sentiment. PBM reforms and biosimilar savings offer offsetting levers for margin recovery.
16 Feb at 04:23
CVS Q4 Beat Lifts Shares; Medicare Rates Bite 2026
CVS Health posted stronger-than-expected Q4 results that pushed the stock higher, but proposed near-flat Medicare Advantage rate changes and insurer margin pressures keep downside risk for Aetna. Investors are weighing resilient retail/PBM performance against reimbursement and regulatory headwinds.
09 Feb at 04:22
CVS Plunges After CMS MA Rate Shock, PBM Rules Now
A near-flat CMS Medicare Advantage rate proposal and fresh PBM transparency rules rattled CVS this week, triggering a sharp stock drop and renewed scrutiny of Aetna and Caremark revenue drivers. Operational cuts and broader sector moves provide context for investors reassessing near-term outlook.